Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate/Severe Asthma”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00180011
What this trial is testing

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
DiMango, Emily, M.D. 18
Large-scale testing (Phase 3)UnknownNCT03387241
What this trial is testing

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Who this might be right for
Asthma
Mundipharma (China) Pharmaceutical Co. Ltd 330
Testing effectiveness (Phase 2)Ended earlyNCT02219048
What this trial is testing

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Who this might be right for
Asthma
Pfizer 51
Testing effectiveness (Phase 2)Study completedNCT01312961
What this trial is testing

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sanofi 104
Post-approval studies (Phase 4)Ended earlyNCT04195958
What this trial is testing

Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Who this might be right for
Moderate-to-severe Allergic Asthma
Genentech, Inc. 3
Not applicableStudy completedNCT05642728
What this trial is testing

Impact of a PERsonalized CAse MAnagement Program for the Follow-up of Moderate and Severe aSTHma Patients on Exacerbations, Health Resource Use and Asthma Control: PERCASTHMA STUDY

Who this might be right for
AsthmaCase ManagementTelemedicine
MurciaSalud 120
Testing effectiveness (Phase 2)Study completedNCT05421598
What this trial is testing

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

Who this might be right for
Asthma
Sanofi 437
Not applicableLooking for participantsNCT07709754
What this trial is testing

PULmonary Stimulation for Asthma Relief

Who this might be right for
Moderate to Severe Asthma
Spiro Medical, Inc. 30
Not applicableStudy completedNCT02808689
What this trial is testing

Functional Medicine in Asthma (FAst) Study

Who this might be right for
Asthma
The Cleveland Clinic 48
Not applicableStudy completedNCT00200980
What this trial is testing

Importance of Non-Acid Reflux in Asthma in Children

Who this might be right for
AsthmaGastroesophageal Reflux
Nemours Children's Clinic 120
Not applicableWithdrawnNCT02347462
What this trial is testing

Bilevel Positive Airway Pressure (BiPAP) for the Treatment of Moderate to Severe Acute Asthma Exacerbations

Who this might be right for
AsthmaStatus Asthmaticus
University of British Columbia
Not applicableUnknownNCT01776177
What this trial is testing

The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy

Who this might be right for
Allergic Asthma
Joseph D. Diaz, MD 240
Testing effectiveness (Phase 2)WithdrawnNCT03277170
What this trial is testing

Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations

Who this might be right for
Asthma; StatusAsthma in ChildrenAsthma Acute+2 more
Vanderbilt University Medical Center
Not applicableWithdrawnNCT01144910
What this trial is testing

The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children

Who this might be right for
Intrinsic AsthmaAllergic AsthmaAllergy+1 more
Johann Wolfgang Goethe University Hospital
Testing effectiveness (Phase 2)Study completedNCT04570657
What this trial is testing

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

Who this might be right for
Asthma
AstraZeneca 250
Large-scale testing (Phase 3)Study completedNCT00747318
What this trial is testing

A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005

Who this might be right for
Asthma
SkyePharma AG 280
Early research (Phase 1)Study completedNCT02573155
What this trial is testing

Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

Who this might be right for
Asthma (Part 1)COPD (Part 2)
AstraZeneca 134
Not applicableStudy completedNCT01891630
What this trial is testing

Observational Assessment of Baseline Asthma Control in African-American Children

Who this might be right for
Asthma
University of North Carolina, Chapel Hill 25
Testing effectiveness (Phase 2)Study completedNCT01070524
What this trial is testing

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 113
Testing effectiveness (Phase 2)Study completedNCT05251259
What this trial is testing

Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma

Who this might be right for
Asthma
AstraZeneca 670
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation